國立虎尾科技大學 |

Pharmaceutical medicine, biotechnology, and European law /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Pharmaceutical medicine, biotechnology, and European law // edited by Richard Goldberg and Julian Lonbay.
其他題名:	Pharmaceutical Medicine, Biotechnology & European Law
其他作者:	Goldberg, Richard,
面頁冊數:	1 online resource (xxxv, 241 pages) :digital, PDF file(s). :
附註:	Title from publisher's bibliographic system (viewed on 05 Oct 2015).
標題:	Pharmacy - Law and legislation - Europe. -
電子資源:	https://doi.org/10.1017/CBO9780511560125
ISBN:	9780511560125 (ebook)

Pharmaceutical medicine, biotechnology, and European law /
Pharmaceutical medicine, biotechnology, and European law /Pharmaceutical Medicine, Biotechnology & European Lawedited by Richard Goldberg and Julian Lonbay. - 1 online resource (xxxv, 241 pages) :digital, PDF file(s).

Title from publisher's bibliographic system (viewed on 05 Oct 2015).

1. Free movement of goods and persons, competition and intellectual property -- 2. European drug regulation -- 3. Biotechnology -- 4. Product liability and transnational health care litigation.

European law has been faced with increasingly complex issues emerging from rapid developments in pharmaceutical medicine and biotechnology. A team of distinguished European legal practitioners and academics reassess the impact of European law on health care and pharmaceutical law. The essays are grouped under four themes: Free movement of goods and persons, competition and intellectual property; European drug regulation; Biotechnology; and Product liability and transnational health care litigation. The book reviews the impact of European law on movement of health care professionals and pharmaceuticals, patent and trademark rights, the Product Liability Directive, laws on product liability and intellectual property claims. It examines recent developments in drug regulation, particularly data protection, abridged applications for marketing authorisations and the European Medicines Evaluation Agency. A compelling analysis is made of the Biotechnology Directive morality clauses. This important study offers a valuable resource for the pharmaceutical and biotechnology industries, legal academics and practitioners alike.

ISBN: 9780511560125 (ebook)Subjects--Topical Terms:

801566
Pharmacy
--Law and legislation--Europe.

LC Class. No.: KJC6191 / .P48 2000

Dewey Class. No.: 344/.04233/094

Pharmaceutical medicine, biotechnology, and European law /
LDR:02435nam a2200313 i 4500 001 1124420
003 UkCbUP
005 20151005020624.0
006 m|||||o||d||||||||
007 cr||||||||||||
008 240926s2000||||enk o ||1 0|eng|d
020 $a 9780511560125 (ebook)
020 $z 9780521792493 (hardback)
035 $a CR9780511560125
040 $a UkCbUP $b eng $e rda $c UkCbUP
043 $a e------
050 0 0 $a KJC6191 $b .P48 2000
082 0 0 $a 344/.04233/094 $2 21
245 0 0 $a Pharmaceutical medicine, biotechnology, and European law / $c edited by Richard Goldberg and Julian Lonbay.
246 3 $a Pharmaceutical Medicine, Biotechnology & European Law
264 1 $a Cambridge : $b Cambridge University Press, $c 2000.
300 $a 1 online resource (xxxv, 241 pages) : $b digital, PDF file(s).
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Title from publisher's bibliographic system (viewed on 05 Oct 2015).
505 0 $a 1. Free movement of goods and persons, competition and intellectual property -- 2. European drug regulation -- 3. Biotechnology -- 4. Product liability and transnational health care litigation.
520 $a European law has been faced with increasingly complex issues emerging from rapid developments in pharmaceutical medicine and biotechnology. A team of distinguished European legal practitioners and academics reassess the impact of European law on health care and pharmaceutical law. The essays are grouped under four themes: Free movement of goods and persons, competition and intellectual property; European drug regulation; Biotechnology; and Product liability and transnational health care litigation. The book reviews the impact of European law on movement of health care professionals and pharmaceuticals, patent and trademark rights, the Product Liability Directive, laws on product liability and intellectual property claims. It examines recent developments in drug regulation, particularly data protection, abridged applications for marketing authorisations and the European Medicines Evaluation Agency. A compelling analysis is made of the Biotechnology Directive morality clauses. This important study offers a valuable resource for the pharmaceutical and biotechnology industries, legal academics and practitioners alike.
650 0 $a Pharmacy $x Law and legislation $z Europe. $3 801566
650 0 $a Drugs $x Law and legislation $z Europe. $3 801564
650 0 $a Biotechnology industries $x Law and legislation $z Europe. $3 801563
650 0 $a Medical laws and legislation $z Europe. $3 801565
700 1 $a Goldberg, Richard, $d 1967- $e editor. $3 1441939
700 1 $a Lonbay, Julian, $e editor. $3 1441940
776 0 8 $i Print version: $z 9780521792493
856 4 0 $u https://doi.org/10.1017/CBO9780511560125